Search
IRadimed Corp
IRMDAdd to Watchlist
90.860USD
-4.350-4.57%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.16BMarket Cap
49.02P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of IRadimed Corp is 8.00, ranking 69 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 99.00, with a high of 100.00 and a low of 98.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
118.000
Target Price
+29.87%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
IRadimed Corp
IRMD
2
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is IRadimed Corp's expected revenue for the next quarter?
IRadimed Corp's expected revenue is 20.35M.
What is IRadimed Corp's price target?
Analysts forecast that IRadimed Corp's price target is USD 99.00, with the highest forecast at USD 100.00 and the lowest forecast at USD 98.00.
How have IRadimed CorpIRMD's recent earnings per share performed?
The market expectation was USD 0.46, while IRadimed CorpIRMD's earnings per share (EPS) for the previous quarter was USD 0.51. EPS for the next quarter is expected at USD 0.42.
What is the analyst rating for IRadimed Corp?
Based on the ratings of IRadimed Corp's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.